Go offline with the Player FM app!
1479: Dr. Tom Jelinek Digs Into Diabetes Down To The Cellular Level Embracing A Ketogenic Diet
Archived series ("Inactive feed" status)
When? This feed was archived on March 09, 2023 13:12 (). Last successful fetch was on January 23, 2023 10:11 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 228180473 series 2279160
Tom Jelinek earned his PhD in 1993 from McMaster University, studying cellular regulatory processes. He then joined the Cancer Center at the University of Virginia Medical School, where he furthered his studies on the mechanisms of cell signaling. At age 51, Tom was diagnosed with type II diabetes, with a blood glucose reading of 325 mg/dl (18 mM). But instead of turning to medication, he returned to his roots, and began to ask what went wrong, and whether it could be cured by reversing what went wrong. The result was a halving of blood glucose in under a month, and full reversal of diabetes in under three months.
Listen in today as Jimmy and Dr. Jelinek talk about:
- How he came to write his book Goodbye, Pills & Needles: A Total Re-Think of Type II Diabetes. And A 90 Day Cure
- How he learned to go against the grain of mainstream opinion
- How medicine fundamentally misunderstands what insulin is
- Type I versus Type II Diabetes
- What happens to glucose, after drugs force reluctant cells to take it up
- Metformin, and what it really does
- Heart Disease, and the current guidelines.
- Blood pressure, and how type II diabetes affects it
- The cancer risk of excessive glucose
- The attitudes of the medical system
- and more
472 episodes
Archived series ("Inactive feed" status)
When? This feed was archived on March 09, 2023 13:12 (). Last successful fetch was on January 23, 2023 10:11 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 228180473 series 2279160
Tom Jelinek earned his PhD in 1993 from McMaster University, studying cellular regulatory processes. He then joined the Cancer Center at the University of Virginia Medical School, where he furthered his studies on the mechanisms of cell signaling. At age 51, Tom was diagnosed with type II diabetes, with a blood glucose reading of 325 mg/dl (18 mM). But instead of turning to medication, he returned to his roots, and began to ask what went wrong, and whether it could be cured by reversing what went wrong. The result was a halving of blood glucose in under a month, and full reversal of diabetes in under three months.
Listen in today as Jimmy and Dr. Jelinek talk about:
- How he came to write his book Goodbye, Pills & Needles: A Total Re-Think of Type II Diabetes. And A 90 Day Cure
- How he learned to go against the grain of mainstream opinion
- How medicine fundamentally misunderstands what insulin is
- Type I versus Type II Diabetes
- What happens to glucose, after drugs force reluctant cells to take it up
- Metformin, and what it really does
- Heart Disease, and the current guidelines.
- Blood pressure, and how type II diabetes affects it
- The cancer risk of excessive glucose
- The attitudes of the medical system
- and more
472 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.